
Therapeutic Innovations
Therapeutic Innovations is dedicated to redesigning medical devices for developing countries without compromising on quality.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
$75.0k | Convertible | ||
Total Funding | 000k |
Related Content
Therapeutic Innovations Inc. operates as a for-profit social enterprise focused on developing medical devices to enhance healthcare accessibility in developing nations. The company was co-founded by Solomon Kofi Arko Mensah, who serves as CEO, and Anwar Upal. Mensah is pursuing a Ph.D. in Biomedical Engineering at Northeastern University and has experience leading multifunctional teams in product development for medical devices and vascular regeneration. The company's primary mission is to address infant mortality resulting from Respiratory Distress Syndrome (RDS) in these regions.
The core of their business is the development of affordable and effective medical technology. Their flagship product, currently patent-pending, is the airbabyTM, a respiratory assist bubble CPAP (bCPAP) device designed to help infants, particularly premature babies, breathe. A significant portion of the business model revolves around creating devices that are not only low-cost but also suited for environments with limited resources. Therapeutic Innovations has received grant funding from notable partners including the National Science Foundation, Northeastern University, and the Black Ambition Fund to support its operations and product development. The company targets hospitals and clinics in developing countries that face challenges in affording and maintaining standard medical equipment.
The airbabyTM device is engineered to provide most of the functionality of more expensive, gold-standard equipment at a substantially lower price point. Its key features include being fully transportable, operable on both grid and battery power for regions with unreliable electricity, and designed with reusable consumables that can be sanitized. The device's modular design facilitates easy maintenance and repair. While the airbabyTM is not yet commercially available pending FDA regulatory approval, the company has engaged with over 100 clinicians to ensure the product meets the critical needs of its intended users, such as oxygen/air blending, pressure regulation, and humidification.
Keywords: medical devices, pediatric care, neonatal health, developing countries, respiratory distress syndrome, bCPAP, affordable healthcare, social enterprise, global health, infant mortality, medical technology for emerging markets, airbaby, Solomon Kofi Arko Mensah, low-cost medical equipment, transportable medical devices, battery-operated medical devices, healthcare accessibility, Northeastern University, National Science Foundation, Black Ambition Fund